Anixa Biosciences, Inc.
- ANIX
- NASDAQ
- Biotechnology
- Cancer Therapies
- Infectious Disease Vaccines
$2.61
Today −2.25%Quote Oct 19, 2026, 08:00 PM UTC
−5.78%over the last month
Max drawdown −13.6%From 1-month high −13.6%3 months −26.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Anixa Biosciences
Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within the fields of oncology (cancer) and infectious diseases.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
4
Market value
$90.7M
Quote Oct 19
Analyst target
$6.00
+129.9% from here
Floor
$2.60
0.4% below price
Resistance
$2.74
5.0% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ANIXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free